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Summary 26 
South Asians, particularly when living in high-income countries, are at significantly elevated 27 
risk of type 2 diabetes compared to white Europeans, and typically develop the disease 5-10 28 
years earlier and at a lower body mass index.  Migrant South Asians appear more insulin 29 
resistant than white Europeans across the life-course and potentially experience beta cell 30 
exhaustion at an earlier age.  Current evidence suggests that differences in both adiposity 31 
(higher percent body fat, greater proportion of deep subcutaneous and visceral fat) and 32 
skeletal muscle (lower percent lean mass, lower cardiorespiratory fitness) are likely to 33 
contribute. There is currently no clear evidence for genetic factors making a major 34 
contribution to South Asians increased diabetes but epigenetic factors may play a role. 35 
Regardless of future mechanistic discoveries, South Asians need to be encouraged and helped 36 
(via multiple, culturally efficient methods) to maintain high physical activity levels and lower 37 
body weights across the life-course to prevent diabetes. In clinical terms, cardiovascular risks 38 
have attenuated over time in migrant South Asians with diabetes but retinopathy and renal 39 
complication risks remain high due to their higher levels of glycaemia and more rapid 40 
glycaemic deterioration over time. We critically review these aspects and suggest areas for 41 
future research.  42 
  43 
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Key messages Panel 44 
Proposed guidance/recommendations for clinicians and public health officials 45 
• Migrant South Asians have a 2-4 fold higher risk of diabetes independent of adiposity, 46 
and develop diabetes on average 5-10 years earlier compared with  47 
white Europeans.  This excess risk is best captured in country or region-specific 48 
diabetes risk scores which include ethnicity as a predictor. 49 
• Screening for diabetes (using HbA1c or fasting glucose) in South Asians should either 50 
be guided by ethnicity-specific risk scores or be initiated at lower BMI levels in  than 51 
in white Europeans  52 
• To mitigate such risks, migrant South Asians should have their excess risk explained 53 
in an accessible manner  and encouraged to maintain lower body weights and higher 54 
physical activity levels throughout the life course.   55 
• Current activity levels in migrant South Asians are low. Thus innovative culturally 56 
appropriate interventions to increase physical activity need to be developed and 57 
implemented for both South Asian males and females.  58 
• South Asians appear to progress more rapidly from ‘pre-diabetes’ to diabetes than 59 
white Europeans, and current lifestyle interventions are less effective at preventing the 60 
transition from ‘pre-diabetes’ to diabetes in South Asians.  Thus, lowering the ‘pre-61 
diabetes’ threshold for the initiation of intervention from 6.0% to 5.7% and/or more 62 
intensive lifestyle intervention may be needed for diabetes prevention in South 63 
Asians.  64 
• Once diabetes is diagnosed, migrant South Asians have more rapid deterioration in 65 
glycaemic control. Thus greater efforts to manage the hyperglycaemia by encouraging 66 
(more) intensive lifestyle changes or, if this fails, earlier escalation in oral therapies is 67 
needed to mitigate against higher microvascular risks. Wherever possible, early 68 
diabetes consultations should include health care workers speaking in the patient’s 69 
native language.  70 
• Trials testing efficacy of differing glycaemia-lowering medications in South Asians 71 
are also lacking and would also be useful.      72 
• Early prescription of ACE/ARB medications in migrant South Asians newly 73 
diagnosed with diabetes may be advantageous with a target of <130/80 to mitigate 74 
against microvascular risks.  Future trials in this area would be valuable. 75 
   76 
 77 
 78 
  79 
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South Asians – individuals of Pakistanis, Indians, Bangladeshis and Sri Lankans – represent 80 
almost a quarter of the world’s population.  Many South Asians live outside the Indian 81 
subcontinent with large populations in the UK (approximately 3 million people), Canada (1.6 82 
million), South Africa (1.3 million), the USA (3 million), many European countries, the 83 
Middle-East, Australia and several African countries.  This review concentrates on the 84 
accelerated type 2 diabetes risks in immigrant South Asian populations; however, many 85 
aspects are pertinent to understanding the accelerated diabetes risk in all South Asians.  86 
 87 
Search strategy 88 
We searched PubMed and Google Scholar using the terms ‘South Asian*’, ‘Asian Indian*’,  89 
and keywords: : ‘diabetes’, ‘impaired glucose tolerance’, ‘insulin*’, ‘glucose’, ‘obesity’,  90 
‘adipose tissue’, ‘ectopic fat’, ‘muscle’, ‘liver’, ‘lifestyle’, ‘fitness’, ‘physical activity’, 91 
‘gene*’, ‘early origins’, ‘fetal programming’, ‘diet’  and selected relevant papers published in 92 
English from January 1970 to June 2015. In places we used our judgement to select 93 
representative papers or reviews to illustrate key points and issues rather than provide an 94 
exhaustive list of all the available studies on a particular topic. 95 
 96 
Epidemiology of type 2 diabetes in migrant South Asians 97 
How high is diabetes risk in South Asians? 98 
Immigrant South Asians generally have greater prevalence of type 2 diabetes than the 99 
background populations of countries they move to (1-5). Relative to white people of 100 
European descent, South Asians living in high-income countries have age-standardised rates 101 
of type 2 diabetes around 2-4 fold higher, with these risks appearing highest in Bangladeshis 102 
(around 4-fold ) and lowest in Indians (around 2-fold) (2;6).   Of particular note, increased 103 
risk for diabetes is observed at much lower levels of  body mass index (BMI) in all migrant 104 
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South Asian groups (1;7), as recently demonstrated using UK Biobank data (Figure 1) (1).  105 
Consequently, the American Diabetes Association (ADA) recently recommended lowering 106 
the threshold for diabetes screening to BMI ≥23 kg.m-2 in Asian Americans (8) and the UK 107 
National Institute for Health and Care Excellence (NICE) have recommended thresholds of 108 
23 kg.m-2 and 27.5 kg.m-2 to identify South Asians at ‘increased’ and ‘high’ risk of type 2 109 
diabetes (9).  However, the ADA and NICE BMI thresholds are pragmatic and an alternative 110 
more holistic approach would be to capture the South Asians’ excess risk by incorporating 111 
ethnicity as a risk multiplier in diabetes risk scores (6).  112 
 113 
 114 
At what age does the higher risk of type 2 diabetes in South Asians become evident?  115 
A recent report from the Born in Bradford study demonstrated ~10% higher umbilical cord 116 
insulin levels in South Asian, compared with white European neonates born in the UK 117 
despite lower birth weights (10), suggesting greater insulin resistance at birth, extending  118 
earlier findings in South Asian neonates born in India compared with white European babies 119 
in the UK (11).  Furthermore, South Asians in the UK appear more insulin resistant than 120 
white Europeans throughout childhood, with observations of higher insulin and triglyceride 121 
concentrations at 8-11 years (12), and higher glucose, insulin and HOMA-estimated insulin 122 
resistance at 13-16 years (13)in the Ten Towns Heart Health Study; and higher HbA1c, 123 
fasting insulin and fasting triglyceride, and lower HDL-cholesterol concentrations in 9-10 124 
year old, despite lower BMIs and waist circumferences, in the CHASE study  (14). These 125 
findings concur with analmost 3-fold greater incidence of type 2 diabetes in UK South Asians 126 
compared with white Europeans aged under 30 years (15).  Incidence of type 2 diabetes 127 
continues to be higher in South Asians throughout middle-age and into later life (16).  South 128 
Asians are typically diagnosed with type 2 diabetes around 5-10 years earlier than white 129 
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Europeans (17-19) and, by the age of 70, 30-40% of British South Asians have type 2 130 
diabetes – at least twice the prevalence in British white Europeans (16).  Thus, metabolic 131 
dysfunction and type 2 diabetes is more common throughout the life-course in South Asians 132 
(Figure 2).  There is also evidence that South Asians may transition through the high risk 133 
‘pre-diabetes’ phase more rapidly than white Europeans.  Data from high-income countries 134 
are lacking, but evidence from the CURES study in India (20), a prospective follow-up of 135 
South African Indians (21), and the control arms of diabetes prevention trials in India (22;23), 136 
suggest an annualised progression rate to diabetes of ~12-18% for South Asians with IGT, 137 
which is substantially higher than the progression rate observed in people with IGT of white 138 
European origin (~5-11%) (24-27).   Thus early intervention for diabetes prevention may be 139 
particularly important in this ethnic group. 140 
 141 
Mechanisms: current hypothesis for why South Asians are at increased risk of diabetes 142 
Increased risk of type 2 diabetes in South Asians probably results from the interaction 143 
between a number of innate and environmental factors. Current hypotheses for the 144 
mechanisms responsible for South Asians’ increased diabetes risk are described in the section 145 
below and summarised in Figure 3.  146 
  147 
Do South Asians have increased genetic predisposition to diabetes? 148 
In a recent meta-analysis of genetic data including 29,618 cases and 40,329 controls from 38 149 
studies, Sohani and colleagues (28) noted 24 single nucleotide polymorphisms (SNPs) from 150 
21 loci were associated with type 2 diabetes in South Asians, with no clear evidence of a 151 
difference between the two ethnic groups in either the type 2 diabetes risk estimates 152 
associated with these SNPs or in their population burden. There is, however, recent evidence 153 
from an epigenome-wide association study in 13535 South Asians and 7066 white Europeans  154 
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in the London Life Sciences Prospective Population (LOLIPOP) study that a DNA 155 
methylation score based on five genes – ABCG1, PHOSPHO1, SOCS3, SREBF1, and 156 
TXNIP – was similarly predictive of type 2 diabetes in white Europeans (relative risk of 1.88 157 
per SD increase) and South Asians (relative risk of 1.68), but that South Asians had a DNA 158 
methylation score 0.86 SD higher than the Europeans.  This ‘explained’ 32% of 2.5-fold 159 
increased diabetes risk in South Asians that was not accounted for by differences in adiposity, 160 
glycaemic measures or physical activity (19).  Such findings require replication, particularly 161 
in children, to help reveal the extent to which this effect is seen early in life, when noise from 162 
cumulative exposure to environmental risk factors is lower than in adulthood (29).    163 
Is there a role for early origins/fetal programming?  164 
A recent meta-analysis showed low birth weight (a marker of fetal undernutrition) to be 165 
associated with greater risk of type 2 diabetes with each kg increase associated with a ~25% 166 
decrease in diabetes risk (30). Whilst South Asians have lower birth weights, a recent 167 
analysis from different ethnicities did not support low birth weight per se as an explanation 168 
for the emerging ethnic difference in risk markers for diabetes (31).  However, South Asian 169 
children have a higher percentage of body fat at birth (based on skin-folds and/or cord leptin 170 
levels), often accompanied by higher cord insulin concentrations commensurate with greater 171 
insulin resistance (10;11).  Of note, when adjustment was made for maternal fasting glucose 172 
levels, which were higher in the (predominantly Pakistani) South Asian women, the ethnic 173 
difference in cord leptin halved and became non-significant (10).  Further analyses of 1,415 174 
women and their singleton live-born infants (629 white British and 786 Pakistani) supported 175 
the hypothesis that maternal fasting glucose levels may mediate the relationship of Pakistani 176 
ethnicity to greater fat mass at birth (10). If correct, future randomised trials investigating the 177 
effects of lifestyle intervention in South Asian pregnant women at elevated risk of gestational 178 
diabetes would seem worthwhile, with key end-points including rates of gestational diabetes, 179 
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birth weights and, critically, neonatal body composition. Such intervention trials are 180 
important to translate the research into the fetal programming hypothesis beyond mere 181 
observations and elucidation of mechanisms to real-world clinical importance.  182 
 183 
Do South Asians have lower pancreatic beta-cell capacity?  184 
In contrast to clear evidence for greater insulin resistance in South Asians, there is less 185 
evidence for inadequate beta-cell capacity.  However some recent data, using indirect 186 
measures, has emerged. Data from the Whitehall study in the UK (32), using HOMA-B% as 187 
an estimate of beta-cell function in 230 South Asian and 5749 white European participants 188 
aged 39-79 at baseline assessed at 5-yearly intervals from 1991-1994 to 2007-2009, suggest 189 
that beta-cell function is higher in South Asians at age 50 years, a finding corroborated by 190 
data from the Southall study (16); however, while HOMA-B% increased in Europeans with 191 
age to compensate for increasing insulin resistance, this did not occur in South Asians, who 192 
experienced a decline in beta cell function from the age of ~60 years onwards (32).  193 
Interestingly, cross-sectional data from the MASALA and MESA studies in the US showed 194 
slightly lower HOMA-B values in South Asians  (mean age 57 years) compared with adults 195 
of white European descent (mean age 63 years) (33).   Furthermore, in the Whitehall study, 196 
there was clear evidence of a sharper rise in fasting plasma glucose in South Asians 197 
compared with white Europeans over time (32). Interestingly, in the Southall study, whilst 198 
adjustment for truncal adiposity and insulin resistance completely attenuated the excess 199 
incident diabetes risk in South Asian women, the excess diabetes risk remained in South 200 
Asian men, suggesting inadequate compensatory beta cell function may contribute (16).  One 201 
limitation of HOMA-B% is that it provides a relatively crude estimate of beta-cell function.  202 
In a study of migrant South Asians in the US, Gujral and coworkers found that the disposition 203 
index – a more dynamic estimate of beta cell function, derived from glucose and insulin 204 
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measures across an OGTT – was more strongly associated with ‘pre-diabetes’ and type 2 205 
diabetes than whole body insulin sensitivity assessed using the Matsuda index.  Clearly, 206 
further detailed assessment of beta cell function in South Asians across the life-course 207 
appears warranted.  In general, whilst South Asians are able to produce more insulin at 208 
younger ages to compensate for their peripheral insulin resistance, it appears that an earlier 209 
decline in beta cell function accompanies transition to dysglycaemia and ultimately diabetes.  210 
Whether these patterns represent earlier beta cell ‘exhaustion’ secondary to higher levels of 211 
insulin production needed throughout the life-course to compensate for insulin resistance; 212 
lower inherent beta cell capacity; more rapid accumulation of ectopic fat around the pancreas; 213 
or some other mechanism such as enhanced hepatic insulin extraction, requires further 214 
investigation. The clinical implications of these findings are also uncertain, though some 215 
speculate that incretin-based therapies may be particularly suitable for South Asians with 216 
diabetes (34).   217 
 218 
Do South Asians have a lower capacity for safe fat storage than Europeans? 219 
In observational studies, the increase in diabetes risk per unit increase in BMI or waist 220 
circumference is substantially greater in South Asians than Europeans (1;7) suggesting that 221 
the adverse metabolic effects of increasing adiposity may be greater in South Asians.  Indeed, 222 
while South Asians carry more body fat than Europeans and this is distributed more centrally 223 
(35-38), they remain more insulin resistant than Europeans after adjustment for a range of 224 
adiposity markers (38-40).  However, these relatively crude adjustments do not account for 225 
potential differences in adipose tissue morphology or function.  Whilst there is evidence that 226 
excess subcutaneous truncal fat is associated with insulin resistance (41),  it has been 227 
postulated that accumulation of fat in primary superficial subcutaneous adipose tissue depots 228 
is relatively benign, whereas fat accumulation in secondary deep subcutaneous, visceral and 229 
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ectopic depots is associated with metabolic dysfunction (42-44) .  Accordingly, it has been 230 
hypothesised that South Asians have a lower capacity to store fat in the primary superficial 231 
subcutaneous adipose tissue compartment than Europeans resulting in earlier ‘overflow’ into 232 
more harmful secondary depots – the adipose tissue overflow hypothesis (44;45).  Indeed, the 233 
available data generally indicate that South Asians store a larger proportion of their total 234 
and/or abdominal fat in deep subcutaneous and visceral depots compared with Europeans 235 
(35;44-49).  Nevertheless, such data are limited by their cross-sectional nature and further 236 
longitudinal or intervention trial data are needed to confirm whether South Asians do start to 237 
accumulate deep subcutaneous and visceral fat earlier than white Europeans as they increase 238 
adiposity, and whether this contributes to their increased susceptibility to diabetes. 239 
 240 
Observations of adipose tissue distribution do not address underlying mechanisms 241 
responsible for the hypothesised reduced fat storage capacity in South Asians.  Chandalia and 242 
colleagues reported that South Asian men have a larger mean subcutaneous abdominal 243 
adipocyte size than Europeans (35), and Anand co-workers reported that South Asians had 244 
greater subcutaneous abdominal adipocyte area and larger adipocyte maximum diameter than 245 
Europeans (45).  However, recent evidence suggests that adipocyte size follows a bi-modal or 246 
tri-modal distribution, which is not adequately described by simply reporting mean adipocyte 247 
size (50-52).  These studies suggest that insulin resistant obesity is characterised by an 248 
increased proportion of small adipose cells (50;51) and larger large adipose cells (50;52).  249 
This has been interpreted to reflect an inability for small adipose cells to terminally 250 
differentiate into mature adipose cells and increase triglyceride storage in insulin resistant 251 
individuals, which leads to increased size of the limited pool of large adipocytes and earlier 252 
storage in ectopic depots (50;51).  Indeed, adipogenic gene expression in the insulin resistant 253 
obese appears reduced (50;53).  Consistent with these reports, a recent study reported that 254 
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South Asians have both a higher ratio of small-to-larger adipocytes, and a larger fraction of 255 
very large adipocytes than Europeans (54).   However, once again, such data are limited by 256 
their cross-sectional nature, and longitudinal and/or intervention data are needed to ascertain 257 
whether differences exist between South Asians and Europeans in adipocyte size changes 258 
with weight gain; the molecular mechanisms responsible; and whether these changes 259 
contribute to the observed ethnic differences in diabetes risk.  260 
 261 
One consequence of the adipose tissue overflow hypothesis in South Asian would be 262 
accumulation of greater levels of liver fat at any given level of adiposity, which has been 263 
recently examined(45;55).  One report observed higher liver fat only in South Asian men 264 
(55), whereas another found the ethnic difference in liver fat to be more pronounced in 265 
women (45).  Interestingly, liver fat content remained ~2-fold higher in South Asian 266 
compared with European men after adjustment for insulin sensitivity in the former report 267 
(55), suggesting that the relationship between liver fat content and insulin sensitivity may not 268 
be identical across ethnic groups.  Clearly, further studies are needed in this area, which 269 
should also include pancreatic fat measurements.    270 
 271 
There has been recent interest in brown adipose tissue (BAT) which is a heat generating form 272 
of fat with positive effects on energy homeostasis (56;57), adiposity (58) and glucose 273 
metabolism (58;59). Two studies have investigated potential differences in BAT between 274 
South Asians and white Europeans with conflicting findings (60;61), thus further research is 275 
needed..   276 
 277 
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Is lower lean body mass / skeletal muscle mass implicated? 278 
South Asians have proportionately less lean tissue than white Europeans for a given BMI.  As 279 
skeletal muscle is the quantitatively the most important site of glucose disposal (62), it is 280 
conceivable that this could contribute to their greater insulin resistance and diabetes risk.  281 
Lear and colleagues reported that South Asian men and women (n=202)  had higher body fat 282 
percentages, lower lean mass, a higher fat-to-lean mass ratio and were more insulin resistant 283 
than Europeans (n=208) (63).  South Asians remained more insulin resistant than Europeans 284 
after adjustment for fat mass, but the ethnic difference in insulin resistance was no longer 285 
significant after adjustment for the fat-to-lean mass ratio, implying a contribution of lean 286 
tissue to South Asians’ excess insulin resistance (63).  Similarly, in a study of 514 South 287 
Asians and 669 Europeans aged 56-86 years, Eastwood and colleagues reported that South 288 
Asian men and women had lower thigh muscle cross-sectional areas, and that thigh muscle 289 
area was significantly negatively associated with HbA1c in South Asians (but not Europeans) 290 
in analyses adjusted for relevant confounders (47).  Thigh muscle adjustment attenuated the 291 
excess diabetes risk observed in the South Asians independently of visceral adipose tissue 292 
(47).  Thus, lower lean mass may contribute to the increased diabetes risk in South Asians 293 
but, from the available data, it is difficult to fully disentangle the potential independent 294 
effects of lower lean mass vs greater fat mass on metabolic profile and diabetes risk.  295 
Resistance exercise, which increases muscle mass, could conceivably become an important 296 
strategy (together with weight loss and increased aerobic physical activity) for diabetes 297 
prevention in South Asians and randomised controlled trials to determine the efficacy of this 298 
approach are needed.    299 
 300 
Do lower levels of physical activity and fitness play a role? 301 
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Epidemiological studies show that low levels of physical activity are associated with 302 
increased risk of type 2 diabetes (64;65), independent of BMI (65), and data from diabetes 303 
prevention lifestyle intervention trials demonstrate the potential for increasing physical 304 
activity to reduce incidence of diabetes, which is evident even in trials in which there was not 305 
significant weight loss (22;66).   A number of studies using both objective accelerometer (67-306 
69) and self-report questionnaire (47;70-73) measures of physical activity have reported that 307 
South Asians living in high-income countries are less active than white Europeans throughout 308 
the life-course.  However, although lower physical activity levels likely to contribute to their 309 
higher level of insulin resistance and diabetes risk , South Asians remain more insulin 310 
resistant than white Europeans after adjustment for difference in physical activity level  311 
(39;67). 312 
 313 
A contributing factor may relate to differences between South Asians and Europeans in the 314 
association between physical activity and cardiorespiratory fitness.  Physical activity is a 315 
behaviour, defined as bodily movements produced by skeletal muscles which results in 316 
energy expenditure, whereas cardiorespiratory fitness is the ability of the cardiovascular and 317 
respiratory systems to supply oxygen to working muscles during sustained physical activity.  318 
There is a relatively strong relationship between level of physical activity and level of 319 
cardiorespiratory fitness (74), however, increasing evidence suggests that South Asians have 320 
lower levels of cardiorespiratory fitness than white Europeans (39;74-76), which cannot be 321 
accounted for differences in physical activity (39;74).  There is substantial epidemiological 322 
evidence that cardiorespiratory fitness level is an important risk factor for type 2 diabetes (77-323 
83), and evidence from animal models supports the likely causality of this relationship (84).  324 
Indeed, adjusting for differences in fitness between South Asian and white European men 325 
attenuated the excess (HOMA-estimated) insulin resistance observed in the South Asians by 326 
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more than two-thirds (74) (Figure 4), although similar studies are needed in women.  As 327 
increases in fitness can only be brought about by physical activity or losing weight (as 328 
maximal oxygen uptake is generally expressed per kg body weight), South Asians need to 329 
engage in greater levels of physical activity and/or have a lower body weight to achieve 330 
comparable levels of fitness (and insulin sensitivity) to white Europeans.  In line with this, 331 
recent Indian physical activity guidelines (85) and the Joint British Societies’ in the UK (86) 332 
have both recommended substantially higher levels of physical activity for South Asians for 333 
diabetes and cardiovascular disease (CVD) prevention, than the current WHO physical 334 
activity recommendation of 150 minutes of moderate intensity physical activity per week 335 
(87).  Given that habitual levels of physical activity are currently lower in South Asians than 336 
Europeans in high-income countries (67-73), realising such a change will be a considerable 337 
but important challenge.   338 
 339 
We have also reported that fat oxidation during sub-maximal exercise (which largely reflects 340 
muscle metabolism) was about 50% lower in South Asian men compared with age and BMI-341 
matched white European men, and that this was associated with lower insulin sensitivity at 342 
both the whole body level and the level of insulin signalling within skeletal muscle (39).  343 
However, paradoxically, despite lower cardiorespiratory fitness and fat oxidation during 344 
exercise, South Asians did not have lower skeletal muscle expression of oxidative and lipid 345 
metabolism genes, and the skeletal muscle mitochondrial to nuclear DNA ratio was similar 346 
between the two ethnic groups, suggesting similar mitochondrial biogenesis (39).  Bakker and 347 
colleagues recently reported that, compared to European men of similar age and BMI, young 348 
normoglycemic South Asian men had a lower mitochondrial to nuclear DNA ratio, but 349 
similar expression of oxidative, lipid and glucose metabolism genes in skeletal muscle (88).  350 
In contrast, data from Nair and co-workers suggest that skeletal muscle capacity for oxidative 351 
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phosphorylation and mitochondrial DNA copy number may be higher, rather than lower, in 352 
South Asians compared with white Europeans (89).  Thus, based on the limited available 353 
data, skeletal muscle mitochondrial dysfunction appears unlikely to account for South Asians 354 
increased insulin resistance although further studies are needed.  There is increasing evidence 355 
that a substantial component of ‘muscle’ insulin resistance may reflect insulin resistance of 356 
the muscle vasculature (90), and impaired endothelial function in forearm resistance vessels 357 
(91) and reduced bioavailability of nitric oxide at rest and during exercise (92) has been 358 
observed in young South Asian compared with white European men.  Thus, impaired skeletal 359 
muscle microvascular function may contribute to increased insulin resistance in South Asians 360 
but further study is needed to quantify the magnitude of any such effect. 361 
 362 
Can a poorer diet explain the excess diabetes risk in migrant South Asians? 363 
There is some evidence that dietary acculturation occurs in migrant South Asians such that, 364 
over time, eating habits become closer to those of the background population in their adopted 365 
country with increased consumption of highly processed foods and meat, and consequently 366 
higher energy and fat intake compared with diets traditionally consumed in South Asia 367 
(93;94).  Nevertheless, reports have suggested energy intakes are similar or lower in migrant 368 
South Asians compared with white Europeans, with mixed reports on differences in dietary 369 
macronutrient composition (95-97).  However, a report from the CHASE study suggested that 370 
South Asian children, particularly those of Bangaldeshi origin, aged 9-10 had higher energy, 371 
fat and protein intakes than white Europeans (98).  Thus, overall, while South Asians’ diets 372 
do appear to change when they migrate to high-income countries, there is no consistent 373 
evidence that their diets are any ‘poorer’ than the diets of the background populations of their 374 
adopted countries.  However, the adverse metabolic effects of a high-fat, high energy diet (or 375 
over-consumption) may be greater in South Asians than Europeans.  In a study of 12 young  376 
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lean South Asian (age 19-25 years, BMI <25 kg.m2) and 12 age and BMI-matched European 377 
men in the Netherlands, overfeeding with 1275 kcal/day (94% fat) for 5 days significantly 378 
increased fasting glucose and insulin (by 48%) concentrations, and reduced insulin sensitivity 379 
(by 20%) in the South Asian but not the European men (88).  Longer term overfeeding 380 
studies would be useful to extend such findings.  381 
 382 
Prevention of type 2 diabetes in South Asians 383 
There have been relatively few lifestyle intervention trials for the prevention of diabetes in 384 
migrant South Asian populations. Recently, the PODOSA trial, reported non-significant 385 
28.4% reduction in progression to diabetes in the lifestyle intervention compared to control in 386 
South Asians with IFG and/or IGT in Scotland (99), although this trial was powered to 387 
address weight loss, rather than incident diabetes.   Nevertheless, this percentage reduction in 388 
diabetes incidence was similar to that observed in the Indian Diabetes Prevention Programme 389 
1, which demonstrated that lifestyle intervention (increased physical activity and healthy diet 390 
advice), metformin, and combined lifestyle and metformin, all induced similar reductions in 391 
diabetes incidence (26-28%) in South Asians with IGT in India (22).  More recently, a trial of 392 
537 patients with IGT in India randomised to a lifestyle modification intervention delivered 393 
by mobile-phone text messages or control, reported a 34% reduction in diabetes incidence 394 
with intervention (23).  Thus, while there is evidence that lifestyle interventions to can reduce 395 
diabetes incidence in South Asians living in India, further trials are needed to demonstrate 396 
effectiveness of such interventions in high-income countries.   It is of note that the percentage 397 
reduction in diabetes incidence with lifestyle intervention in trials in South Asians (28-34%) 398 
appear somewhat lower than that observed in other large diabetes prevention trials (e.g. 58% 399 
reduction in both the DPP and DPS (26;27)), suggesting a more modest effect of the lifestyle 400 
intervention employed to date in reducing diabetes risk in South Asians with ‘pre-diabetes’.   401 
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The corollary of this is that earlier and/or more intensive intervention in South Asians may be 402 
needed to maximise the potential for lifestyle intervention to prevent diabetes in this ethnic 403 
group (Figure 2).  In particular, given the evidence of more rapid acceleration of glycaemia 404 
levels (particularly fasting glucose) throughout adulthood in migrant South Asians, compared 405 
with white Europeans, (32), together with evidence that South Asians living in India 406 
experience a more rapid transition through the ‘pre-diabetic’ stage  (20-23), an extension of 407 
the HbA1c range to categorise ‘high diabetes risk’ or pre-diabetes from 6.0-6.4% (100) to 408 
5.7-6.4% in South Asians, to trigger earlier intervention, may be advantageous. Alternatively, 409 
glycaemia testing could be repeated at shorter periods (e.g. 6 months) in South Asians at 410 
elevated diabetes risk (from questionnaire-based screening), rather than the currently 411 
recommended 12-month interval.  Randomised controlled trials to test the effectiveness of 412 
earlier intervention, more frequent screening and more intensive intervention (which may 413 
include a muscle strengthening component, as well as weight loss and increased aerobic 414 
physical activity) are urgently needed to address this. 415 
   416 
Migrant South Asians with type 2 diabetes – clinical considerations 417 
There is evidence that migrant South Asians with type 2 diabetes experience more rapid year-418 
on-year deterioration in HbA1c than white Europeans in routine clinical practice, despite 419 
greater prescription of oral glycaemic agents (101), implying an ethnic difference diabetes 420 
progression rates. This section examines relative risks in South Asians with type 2 diabetes 421 
living in high-income countries for macro- and micro-vascular complications, and mortality, 422 
and will consider which outcome risks may have declined over time, which require more 423 
study, and which risk factors need further assessment in terms of timing, intensity and goals. 424 
A recent helpful review has called for ethnic specific guidelines for the prevention, diagnosis, 425 
and management of type 2 diabetes in South Asians living on the Indian sub-continent (102). 426 
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Whilst several aspects overlap, particular clinical issues relevant to migrant South Asian 427 
populations are highlighted here.   428 
 429 
Macrovascular complications  430 
Type 2 diabetes per se increases risk of cardiovascular disease (CVD) by around two-fold 431 
(103), and thus the higher CVD risk in South Asians in general must be accounted for, at 432 
least in part, by their greater diabetes prevalence. What is less clear is whether type 2 diabetes 433 
is more strongly linked to CVD in South Asians than white Europeans. Evidence from studies 434 
where type 2 diabetes developed around three decades ago does suggest a greater increase in 435 
CVD risk with diabetes in South Asians, particularly for stroke, in keeping with evidence that 436 
type 2 diabetes development at younger ages is associated with a greater relative increase in 437 
CVD risk than later development (104).  That noted, risks appear to have attenuated over 438 
time. For example, in the Southall studycohort recruited around 1988 and 1991, type 2 439 
diabetes was around twice as strongly related to stroke risk in South Asians and slightly more 440 
strongly related to CHD risk than in white Europeans (105;106). In the UKADS study, where 441 
type 2 diabetes developed around mid-1990s, South Asians had an adjusted odds ratio of 1.4 442 
(0.9 to 2.2) for CVD events compared with white Europeans (107).  A more recent report 443 
from Scotland in which diabetes was diagnosed on average around 2003 noted that excess 444 
CVD risk was apparent only in Pakistanis (HR 1.45) but not Indians (108).  In this latter 445 
study, Pakistanis had poorer glycaemia and developed diabetes earlier than did Indians, in 446 
keeping with their higher risks. Finally, in a large population cohort from Canada which 447 
examined CVD risks over time in newly diagnosed type 2 diabetes patients between 2002 to 448 
2009, hazard ratios for CHD were similar in South Asians and Europeans, and though this 449 
study did not adjust for some important risk factors such as smoking and obesity, overall 450 
mortality risks were also less (109). Overall, it appears that CVD risks associated with type 2 451 
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diabetes in migrant South Asians may have declined over time.  This pattern would be 452 
consistent with improvement in risk factor management in South Asians with type 2 diabetes, 453 
particularly in lipids and blood pressure (particularly important to lowering CVD risk in 454 
diabetes (110)), and potentially earlier pick-up of diabetes commensurate with greater 455 
glycaemia testing in general.  Furthermore, as South Asians develop T2DM at a younger age, 456 
and as recommendations to treat all adult type 2 diabetes patients (>40 years of age) with 457 
statin gained wider acceptance, south Asians may have gained greater relative CVD benefit 458 
(thus attenuating their higher risk) by having an earlier and therefore longer exposure to 459 
statins than white Europeans with type 2 diabetes. The same observation may also apply to 460 
earlier exposure to anti-hypertensive use in South Asians with diabetes, though there appears 461 
room for further improvement in uptake of anti-hypertensive therapy to mitigate 462 
microvascular risks which remain high (discussed below). Future trials assessing benefit to 463 
risk ratios of ethnic-specific treatment targets in blood pressure would be useful.   464 
 465 
Total mortality risks 466 
This is an area less well studied but interestingly, contemporary data from the UK National 467 
Diabetes Audit reported lower short term mortality risks in South Asians with type 2 diabetes 468 
relative to comparable white Europeans (111), in line with emerging evidence discussed 469 
above from Canada (107).  Whether these observations reflects lower non-cardiac death rates 470 
or are, to some extent, influenced by earlier age of diagnosis and thus earlier exposure to 471 
CVD preventative therapies in South Asians merits further study.   472 
 473 
Microvascular complications 474 
South Asians with type 2 diabetes appear to have a greater prevalence of retinopathy than 475 
white Europeans. In the UK Asians Diabetes Study, conducted around 7-10 years post-476 
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diagnosis, age and sex-standardised retinopathy prevalence was significantly higher in South 477 
Asians than white Europeans (43.3% vs 37.2%), with a borderline difference in maculopathy 478 
(14.4% vs 8.8%) (112).  Similarly, in a South African-based study, Thomas and colleagues 479 
reported ~2-fold higher rates for both retinopathy and referable retinopathy in South Asians 480 
compared with white Europeans, assessed about 5 years post-diagnosis (113) .  Interestingly, 481 
in the South London Diabetes (SOUL-D) cohort, in which patients were recruited within 6 482 
months of diagnosis, prevalence of retinopathy in South Asians and white Europeans was 483 
similar (17.0% vs 16.6%), although South Asians were on average 7 years younger and had 484 
lower systolic blood pressure (114).  HbA1c concentrations were higher in the South Asians 485 
compared with Europeans in each of these reports (112-114), in keeping with their greater 486 
retinopathy risks.  As this higher glycemia was already evident at or early after diagnosis 487 
(114), delayed diagnosis, or lesser response to early diabetes treatment or more rapid 488 
progression may contribute.   489 
 490 
The available evidence suggests that microalbuminuria prevalence is similar or lower in 491 
South Asians compared with white Europeans early after diagnosis of type 2 diabetes (114), 492 
but about 1.4-2 fold higher 9-20 years post-diagnosis (17;115).  In a longitudinal study in the 493 
Netherlands, South Asian diabetes patients without microalbuminuria at baseline had 4-fold 494 
higher odds for development of micro- or macroalbuminuria compared with white European 495 
patients, and a 1.45-fold greater decline in glomerular filtration rate (GFR) (116).  This latter 496 
finding was recently corroborated in a multi-ethnic community cohort with diabetes in 497 
London, where the annual decline in GFR was 44% greater in South Asians (117). Taken 498 
together, these findings suggest more rapid progression towards nephropathy in South Asians 499 
with diabetes. Interestingly, in these two longitudinal reports, HbA1c levels were 0.4-0.8% 500 
higher in South Asians than Europeans, but South Asians had lower systolic blood pressure, 501 
21 
 
and similar or lower use of antihypertensive drugs (116;117).  In particular, antihypertensive 502 
use may be lower in South Asians in the early stages of diabetes (114) – perhaps due to their 503 
lower blood pressure and younger age at diagnosis – but catches up with disease progression 504 
as microalbuminuria rates rise more rapidly (117).  Given the above, it is unsurprising that 505 
South Asians have higher risks of developing end-stage renal disease (118).  They do, 506 
however, seem to do well on dialysis with better survival rates than white Europeans, 507 
although, as well documented, they suffer from far lower rates of renal transplantation due to 508 
lack of donors (119).   509 
 510 
Paradoxical to the elevated risks of other microvascular complications, South Asians have 511 
lower neuropathy rates at diagnosis (114) and far lower rates of lower extremity amputations 512 
(120), linked in turn to lower rates of peripheral vascular disease.  Previous work has 513 
suggested lower rates of smoking may contribute to this pattern of risk (120), though further 514 
studies would be useful.  515 
 516 
Implications for clinical care  517 
The foregoing information highlights the need for trials addressing ethnic-specific treatment 518 
targets in migrant South Asians.  For example, consideration of early use of ACE/ARB in 519 
South Asians at the point of type 2 diabetes diagnosis may be helpful. At present, and as 520 
discussed above, South Asians with diabetes seem to have lower antihypertensive use early in 521 
the course of their disease. Nevertheless, their faster progression of retinopathy and 522 
nephropathy suggests they may benefit from earlier use of these medications.  In light of 523 
recent meta-analysis data indicating additional benefits on retinopathy, nephropathy and 524 
stroke from achieving a blood pressure target of <130/80 compared to <140/90 (121), a trial 525 
testing a lower blood pressure threshold (<130/80) in younger South Asians with type 2 526 
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diabetes, with primary end-points of progression of retinopathy and nephropathy, but also 527 
considering safety and quality of life, would be valuable.   528 
 529 
Perhaps most critically, more aggressive management of hyperglycaemia in South Asians 530 
early after type 2 diabetes diagnosis should be considered. This should include 531 
recommending more aggressive lifestyle changes and, where necessary, earlier increments in 532 
oral hypoglycaemia therapies (OHA).  Whether there is a place for dual OHA therapy at 533 
diagnosis in some South Asians requires further study and could be trialled.  There is also a 534 
need to do head to head comparisons of differing OHAs in South Asians to identify which 535 
second line therapies work best and whether different subgroups (by sex, age, adiposity 536 
levels) respond differently. Some observations suggest beta cell function may be a more 537 
important risk factor in transition from normoglycaemia to diabetes in South Asians, whereas 538 
other evidence implicates greater insulin resistance.  It is therefore difficult to predict which 539 
drugs may work best, but given the rapidly rising prevalence of South Asians with type 2 540 
diabetes, this is an area for urgent study.  It would be useful for a study similar to the 541 
GRADE study (122), recently commenced in the US to compare the effectiveness of 542 
commonly used diabetes medications in combination with metformin on glycaemia and 543 
patient centred outcomes, to be repeated in a South Asian population.    544 
 545 
Conclusions and Future Directions 546 
We have reviewed the causes and consequences of higher type 2 diabetes risk in South 547 
Asians, concentrating predominantly on research from high-income countries, and thus from 548 
studies in migrant South Asians. Nevertheless, many aspects have relevance to South Asians 549 
in low and middle income countries where the rise in prevalence of the disease is extremely 550 
worrying.  Based on our assimilation of the evidence, we have suggested a number of areas 551 
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for future mechanistic research, areas for public health consideration and future clinical trials 552 
in South Asian with and without type 2diabetes (summarised in Table 1). It is clear that many 553 
areas require further research investment but in advance of these, the major route to prevent 554 
diabetes in South Asians would be to reverse trends of rising obesity levels since South 555 
Asians appear more sensitive to rising obesity linked in part to differences in body 556 
composition (more fat, with a higher proportion of deep subcutaneous and visceral fat, and 557 
less muscle). Reversing obesity trends in general is no simple task and requires actions on a 558 
number of levels including governmental efforts and changes in food policy and travel 559 
infrastructures. Nevertheless, in advance of any such efforts, it is clear that South Asians need 560 
to be encouraged and helped (via multiple, culturally efficient methods) to maintain high 561 
physical activity levels and lower body weights throughout the life-course to prevent 562 
diabetes. In clinical terms, cardiovascular risks may have attenuated over time in South 563 
Asians with type 2 diabetes due to better blood pressure and lipid management but 564 
retinopathy and renal complication risks remain higher due to more rapid glycaemic 565 
deterioration over time. Thus greater efforts on improving glycaemic control in South Asians 566 
with diabetes are needed. Again we have suggested a number of potential means to address 567 
this.  Further collaborative efforts between researchers in high and low and middle income 568 
countries with substantial South Asian populations should help improve our evidence base in 569 
this important area.  570 
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Table 1.  What is known, and future research directions for mechanisms, mitigation and management of type 2 diabetes in migrant 
South Asians. References for the points in the table made can be found in the main text of the paper. South Asian abbreviated to SA. 
  What is known Future research directions 
Mechanisms Adiposity  SA develop diabetes at much lower BMI than white 
Europeans. For a given BMI, SA have higher fat mass 
and a larger proportion of fat mass in deep abdominal 
subcutaneous and/or visceral depots. Emerging 
evidence for greater liver fat.  
Detailed examination of ectopic fat depots to include more data on 
liver fat and pancreatic fat as determinants of hepatic insulin 
resistance and pancreatic beta cell function, respectively. Detailed 
examination of SA adipose tissue phenotypic features across life-
course and with intentional weight loss and weight gain.  
 
 Lean body 
mass 
SA have a lower proportion of lean mass which appear 
to contribute to their higher insulin resistance and 
diabetes risk. 
Interventions on the effects of resistance exercise to increase lean 
body mass on insulin resistance and diabetes risk in SA. 
 
 Fitness and 
skeletal 
muscle 
function 
SA have lower cardiorespiratory fitness (independent of 
physical activity level) and lower fat rates of fat 
oxidation during submaximal exercise. Both appear to 
contribute to their higher insulin resistance.  However, 
from the available evidence it appears that skeletal 
muscle mitochondrial dysfunction is unlikely to 
account this. 
Interventions using higher intensity exercise to maximise potential 
increases in fitness on insulin resistance and diabetes risk in SA.  
Studies to investigate whether impaired skeletal muscle 
microvascular function contributes to increased insulin resistance. 
 
 
 
 Lifestyle  SAhave lower levels of physical activity than white 
Europeans.   
 
 
 
No clear evidence for diet as major contributor to 
excess type 2 diabetes risk in migrant SA, but emerging 
data that SA may have greater adverse effects of short-
term overfeeding. 
 
Development of novel, culturally appropriate approaches to 
increase physical activity across the life-course in SA.  This is 
particularly important for SA girls where activity levels fall off 
rapidly by secondary school age. 
 
Longer-term intervention trials needed on effects of specific dietary 
manipulations (dietary patterns/energy intake changes) on 
metabolic function/type 2 diabetes risk in SA needed.  This area is 
relatively sparsely studied. 
 Programming Limited evidence for programming role in explaining 
greater SA type 2 diabetes risk. Lower birth weight per 
se does not explain higher risks. Preliminary evidence 
Lifestyle intervention in pregnant SA women to determine if by 
lowering maternal glucose rise is achievable and, if so, whether this 
alters neonate body composition and future offspring metabolic risk 
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that greater maternal hyperglycaemia in SA may 
contribute to greater fat mass in offspring.  
 
profile.  
 Beta cell 
function 
Indirect evidence that beta cell function is higher in SA 
until middle age, but of earlier beta cell decline with 
rising age in SA.  
 
More direct measurements of beta cell function (for example using 
FSIVGTT)  
 Genetics 
/epigenetics 
No current evidence for major differences in genetic 
risk factors for type 2 diabetes between SA and 
Europeans. Some recent evidence for epigenetic signals 
potentially relevant to excess diabetes risk in SA. 
Continued research for type 2 diabetes genes across different 
ethnicities. Replication of epigenetic findings, particularly in 
children who have less cumulative environmental exposure.  
Whether there is any clinical applicability of the epigenetic findings 
in terms of risk prediction needs further investigation. This is 
currently unclear.      
   
Mitigation   Prevention  Evidence for modest type 2 diabetes risk reduction via 
conventional and via mobile phone-facilitated lifestyle 
intervention, and for modest weight reduction with 
family based interventions in SA with impaired glucose 
tolerance. Addition of metformin or pioglitazone to 
lifestyle provided no additional benefit. 
 
Trials of more intensive lifestyle interventions (greater amounts of 
physical activity, larger weight loss, and addition of resistance 
exercise) and/or earlier intervention (see below on widening ‘high 
risk for diabetes’ range). 
 Public health 
measures  
In line with above, preliminary evidence that SA need 
to undergo more physical activity and achieve lower 
BMIs to mitigate metabolic risks.  This is starting to be 
reflected in public health obesity guidance, but not yet 
in physical activity guidance. 
More research needed to determine appropriate levels of physical 
activity to minimise diabetes risk in SA to inform public health 
guidelines.  In addition, research needed on which public health 
measures could cost-effectively lower diabetes risk in SA both in 
developed and developing countries (e.g. sugary drinks tax, 
culturally tailored education programmes, engagement of 
community leaders and media stars as advocates).  Approaches 
taken are likely to be culturally specific and may differ country by 
country.  
 
Management  Screening for 
type 2 diabetes 
or high 
diabetes risk  
SA are known to develop diabetes at younger ages and 
lower BMI than white Europeans and screening 
strategies are appropriately adopted in some countries 
to reflect this.    
All high-income countries with sizeable SA populations should 
develop risk scores for type 2 diabetes which are easy to use and 
include risk multipliers for their major ethnicities (e.g. 
QDIABETES in UK)  
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 Widening 
‘high risk for 
diabetes” or 
“pre-diabetes” 
range 
SA with impaired glucose tolerance or other risk factors 
appear to more rapidly convert to type 2 diabetes 
compared to Europeans, so that less time spent in 
intermediate hyperglycaemia categories. 
  
 
A wider ‘high risk for diabetes’ or pre-diabetes window for SA (i.e. 
HbA1c 5.7 to 6.4% rather than 6.0 to 6.4%) may improve 
preventative efforts by increasing scope for implementation of 
earlier intensive lifestyle intervention   
 Lipids CVD risks in SA with type 2 diabetes appear higher 
than in comparable white Europeans and thus 
mechanisms to lessen risks needed. Statins appear to be 
at least equally effective at lowering cholesterol levels 
in SA and average cholesterol levels in SA and 
Europeans with diabetes appear similar.   
 
Whether all SA with type 2 diabetes above age of 35 years should 
be offered statins (rather than general threshold of 40 years 
recommended in most guidelines) would be usefully examined.   
 Blood 
pressure 
Blood pressure values are broadly similar in SA and 
white Europeans with type 2 diabetes but anti-
hypertensive use appears lower in SA in the early 
stages of disease, perhaps due to younger age at 
diagnosis and lower levels of obesity leading to lower 
perceived risk.   
 
 
Whether early adoption of ACE /ARB in SA at the point of 
diagnosis with type 2 diabetes and lower blood pressure targets than 
in general (<130/80 mm Hg vs. <140/90 mm Hg) would help to 
attenuate excess microvascular risks needs investigation.  Formal 
trials would be useful.  
 Glycaemia  Clear evidence of higher HbA1c at different stages of 
disease (including at diagnosis) in SA with type 2 
diabetes and more rapid progression to treatment with 
insulin. Higher rates of retinal and renal disease in line 
with the foregoing.  
More research is needed on how to lessen glycaemia levels in SA 
with type 2 diabetes.  Specific examples include: the potential role 
of dual therapy at diagnosis in select groups; and more frequent 
visits to monitor HbA1c and progress in early years after diagnosis. 
The efficacy and side effect profiles of different second line 
therapies in SA should be examined in the same way such 
approaches being examined in US (GRADE study). More research 
needed on how to improve compliance with diabetes medications 
and to stimulate /facilitate better adoption of lifestyle changes.    
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Figure Legends 
Figure 1. Age-adjusted associations between diabetes prevalence and adiposity in the 
UK Biobank study.  This figure presents the relationship between diabetes prevalence 
and BMI in white European (black line), Pakistani (red line) and Indian (green line) 
women (left panel) and men (right panel). The horizontal maroon line shows diabetes 
prevalence for white Europeans with BMI 30 kg.m-2, and dotted vertical lines indicate 
BMI values in each ethnic group providing the same diabetes prevalence to that observed in 
white Europeans with BMI 30 kg.m-2.  Modified from reference (1). Copyright 2014 by the 
American Diabetes Association. 
 
Figure 2. Glycaemia over the life-course and the effect of lifestyle intervention on 
diabetes progression in South Asians and white Europeans.  South Asians develop 
diabetes about 5-10 years earlier than Europeans and have more rapid progression from 
impaired glucose tolerance (IGT) to frank diabetes.  Current lifestyle interventions in patients 
with IGT reduce diabetes progression by >50% in Europeans and ~30% in South Asians.  
Thus, to minimise diabetes risk in South Asians earlier and/or more intensive lifestyle 
intervention may be required.  
 
Figure 3. Currently hypothesised mechanisms for South Asians’ increased type 2 
diabetes risk. A combination of innate and environmental factors interact to accelerate 
diabetes risk in South Asians via the potential mechanisms outlined.  Colour intensity of 
boxes indicates the amount of supporting evidence for each factor, with a white background 
denoting the least supporting evidence, and a black background denoting the greatest amount 
of supporting evidence.  
 
Figure 4. Relationship between homeostasis model-estimated insulin resistance 
(HOMAIR) and maximal oxygen uptake (VO2max) in South Asian (solid circles, solid line) 
and European (open circles, dotted line) men.  HOMAIR values displayed as natural 
logarithms. Solid and dotted vertical bars indicate mean VO2max values in South Asian and 
European men, respectively; the horizontal arrow shows the mean difference in VO2max 
between ethnic groups.  Solid and dotted horizontal bars, with corresponding vertical arrows 
indicate mean HOMAIR values in South Asian and European men and the mean ethnic 
difference, both unadjusted and adjusted for VO2max.  Adjustment for VO2max attenuated the 
ethnic difference in HOMAIR by 67.5%.  From reference (74). 
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